Acrivon Therapeutics, Inc.
ACRV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781174
In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Acrivon Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 55 | 63 | +8 |
| Shares | 23.0M | 23.3M | +289.5K (+1.3%) |
| Value | $160.8M | $140.0M | −$20.8M (−12.9%) |
New holders (13)
Institutions that held Acrivon Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acorn Capital Advisors, LLC | 405,237 | $2.44M | 1.31% |
| Pale Fire Capital SE | 15,235 | $91.7K | 0.02% |
| Corton Capital Inc. | 12,159 | $73.2K | 0.04% |
| Wealthedge Investment Advisors, LLC | 10,857 | $65.4K | 0.03% |
| China Universal Asset Management Co., Ltd. | 6,602 | $39.7K | 0.00% |
| BNP Paribas Arbitrage, SA | 1,941 | $11.7K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 1,038 | $6.14K | 0.00% |
| GF Fund Management Co. Ltd. | 654 | $3.94K | 0.00% |
| Redwood Park Advisors LLC | 500 | $3.01K | 0.00% |
| Nisa Investment Advisors, LLC | 100 | $602 | 0.00% |
| SBI Securities Co., Ltd. | 74 | $445 | 0.00% |
| GAMMA Investing LLC | 34 | $205 | 0.00% |
| R Squared Ltd | 20 | $120 | 0.00% |
Sold out (5)
Institutions that held Acrivon Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Exome Asset Management LLC | 116,757 | $817.3K |
| Millennium Management LLC | 39,750 | $278.3K |
| Prelude Capital Management, LLC | 37,727 | $264.1K |
| Capital Performance Advisors LLP | 32 | $224 |
| Avion Wealth | 88 | $0 |